`
`
`
`
`
`
`
`
`
`
`
`
`
`Filed: November 19, 2020
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________
`
` ILLUMINA, INC.,
`Petitioner,
`
`v.
`
` THE TRUSTEES OF COLUMBIA UNIVERSITY
`IN THE CITY OF NEW YORK
`Patent Owner.
`_______________
`
`IPR2020-01177 (Patent 10,435,742)
`
`
`
`PATENT OWNER’S UPDATED EXHIBIT LIST
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2020-01177
`Patent No. 10,435,742
`
`
`Pursuant to 37 C.F.R. § 42.63(e), Patent Owner The Trustees of Columbia
`
`University in the City of New York hereby provides an updated list of its exhibits
`
`in this proceeding.
`
`Exhibit No. Description
`
`EXHIBIT LIST
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`Defendant Illumina, Inc.’s Response to Plaintiffs’ Opening Claim
`Construction Brief
`
`Metzker, et al., “Elimination of residual natural nucleotides from
`3’-O-modified-dNTP syntheses by enzymatic mop-up,”
`BioTechniques, 25:814-817 (1998)
`PCT Publication WO 00/53805 (“Stemple”)
`
`Defendant Illumina, Inc.’s Initial Invalidity Contentions, The
`Trustees of Columbia University in the City of New York and
`Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D. Del.)
`U.S. Patent No. 6,087,095 (“Rosenthal”)
`
`Welch & Burgess, “Synthesis of fluorescent, photolabile 3’-O-
`protected nucleoside triphosphates for the base addition
`sequencing scheme,” Nucleosides & Nucleotides, 18:197-201
`(1999)
`Canard & Sarfati, “DNA polymerase fluorescent substrates with
`reversible 3’-tags,” Gene, 148:1-6 (1994)
`
`IPR2017-02172 Petition for Inter Partes Review of U.S. Patent
`No. 7,566,537
`
`IPR2017-02172 Preliminary Response of Patent Owner Illumina
`Cambridge Ltd.
`
`IPR2017-02174 Preliminary Response of Patent Owner Illumina
`Cambridge Ltd.
`
`2011
`
`IPR2013-00517 Illumina’s Patent Owner Response
`
`
`
`1
`
`
`
`Case IPR2020-01177
`Patent No. 10,435,742
`
`
`2012
`
`IPR2013-00517 Final Written Decision
`
`2013
`
`IPR2013-00517 Deposition of Floyd Romesberg, Ph.D., July 8,
`2014
`
`2014
`
`IPR2018-00291 Petitioner’s Reply
`
`2015
`
`U.S. Patent No. 5,808,045
`
`2016
`
`Curriculum Vitae of Kenneth A. Johnson, Ph.D.
`
`2017
`
`2018
`
`2019
`
`IPR2018-00291, IPR2018-00318, IPR2018-00322, IPR2018-
`00385, IPR2018-00797 Illumina’s Demonstratives for Oral
`Hearing
`IPR2018-00291, IPR2018-00318, IPR2018-00322, IPR2018-
`00385, IPR2018-00797 Illumina’s Reply to Patent Owner’s
`Opposition to Motion to Exclude
`IPR2018-00291 Institution Decision
`
`2020
`
`Exhibit Number Not Used
`
`2021
`
`WO 96/23807 (“Kwiatkowski”)
`
`2022
`
`2023
`
`2024
`
`Ronaghi, et al. “A sequencing method based on real-time
`pyrophosphate,” Science, 281(5375):363-365 (1998)
`
`Brief of Patent Owner-Appellant Illumina Cambridge Ltd.,
`Illumina Cambridge Ltd. v. Intelligent Bio-Systems, Inc., D.I. 27,
`2015-1123 (Fed. Cir.)
`U.S. Patent No. 5,858,671 (“Jones”)
`
`2025
`
`U.S. Patent No. 6,013,445 (“Albrecht”)
`
`2026
`
`Excerpts from the Prosecution History of U.S. Patent No.
`9,718,852
`
`
`
`2
`
`
`
`Case IPR2020-01177
`Patent No. 10,435,742
`
`
`2027
`
`2028
`
`2029
`
`2030
`
`2031
`
`2032
`
`2033
`
`2034
`
`Complaint for Patent Infringement, The Trustees of Columbia
`University in the City of New York and Qiagen Sciences, LLC v.
`Illumina, Inc., D.I. 1, 19-cv-01681 (D. Del.)
`Exhibit Number Not Used
`
`Amended Complaint for Patent Infringement, The Trustees of
`Columbia University in the City of New York and Qiagen
`Sciences, LLC v. Illumina, Inc., D.I. 12, 19-cv-01681 (D. Del.)
`Exhibit 7 to Complaint for Patent Infringement, The Trustees of
`Columbia University in the City of New York and Qiagen
`Sciences, LLC v. Illumina, Inc., D.I. 1-7, 19-cv-01681 (D. Del.)
`Exhibit 8 to Complaint for Patent Infringement, The Trustees of
`Columbia University in the City of New York and Qiagen
`Sciences, LLC v. Illumina, Inc., D.I. 1-8, 19-cv-01681 (D. Del.)
`Docket, The Trustees of Columbia University in the City of New
`York and Qiagen Sciences, LLC v. Illumina, Inc., 19-2302 (Fed.
`Cir.)
`Zhu, Z., et al., “Directly labeled DNA probes using fluorescent
`nucleotides with different length linkers,” Nucleic Acids Res.,
`22:3418-3422 (1994)
`IPR2018-00291, Petition for Inter Partes Review of U.S. Patent
`No. 9,718,852
`
`2035
`
`U.S. Patent No. 7,566,537
`
`2036
`
`2037
`
`2038
`
`Joint Claim Construction Brief, The Trustees of Columbia
`University in the City of New York and Qiagen Sciences, LLC v.
`Illumina, Inc., D.I. 54, 19-cv-01681 (D. Del.)
`Excerpts of Joint Claim Construction Appendix (Declaration of
`John Kuriyan, Ph.D. in Support Of Plaintiffs’ Opening Claim
`Construction Brief; Expert Declaration of Dr. Floyd Romesberg in
`Support of Illumina’s Response to Plaintiffs’ Opening Claim
`Construction Brief), The Trustees of Columbia University in the
`City of New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I.
`55, 19-cv-01681 (D. Del.)
`Exhibit Number Not Used
`
`
`
`3
`
`
`
`Case IPR2020-01177
`Patent No. 10,435,742
`
`
`2039
`
`IPR2012-00007 Illumina Reply
`
`2040
`
`IPR2012-00007 Illumina Expert Declaration
`
`2041
`
`IPR2012-00007 Illumina Petition
`
`2042
`
`2043
`
`2044
`
`2045
`
`2046
`
`2047
`
`Claim Construction Order, The Trustees of Columbia University in
`the City of New York and Qiagen Sciences, LLC v. Illumina, Inc.,
`D.I. 60, 19-cv-01681 (D. Del.)
`Plaintiffs’ Motion for Reconsideration of the Court’s Claim
`Construction Order, The Trustees of Columbia University in the
`City of New York and Qiagen Sciences, LLC v. Illumina, Inc., D.I.
`63, 19-cv-01681 (D. Del.)
`Defendant Illumina, Inc.’s Answer to Plaintiffs’ Motion for
`Reconsideration of the Court’s Claim Construction Order, D.I. 64,
`19-cv-01681 (D. Del.)
`Docket, The Trustees of Columbia University in the City of New
`York and Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-01681 (D.
`Del.) (printed 10/2/2020)
`Protective Order, The Trustees of Columbia University in the City
`of New York and Qiagen Sciences, LLC v. Illumina, Inc., 19-cv-
`01681 (D. Del.)
`Exhibit Number Not Used
`
`2048
`
`Declaration of Kenneth A. Johnson
`
`
`
`Dated: November 19, 2020
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`/John P. White/
`By:
`John P. White, Reg. No. 28,678
`Lead Attorney for Patent Owner
`Cooper & Dunham LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`Telephone: (212) 278-0400
`
`
`
`
`4
`
`
`
`Case IPR2020-01177
`Patent No. 10,435,742
`
`
`
`
`
`
`
`
`Fax: (212) 391-0525
`
`Gary J. Gershik, Reg. No. 39,992
`Cooper & Dunham LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`Telephone: (212) 278-0400
`Fax: (212) 391-0525
`
`John D. Murnane, Reg. No. 29,836
`VENABLE LLP
`JDMurnane@Venable.com
`1290 Avenue of the Americas
`New York, NY 10104
`Telephone: (212) 218-2100
`Fax: (212) 218-2200
`
`Justin J. Oliver, Reg. No. 44,986
`VENABLE LLP
`JOliver@Venable.com
`600 Massachusetts Ave.
`Washington, D.C. 20001
`Tel: (202) 721-5423
`Fax: (212) 218-2200
`
`
`5
`
`
`
`Case IPR2020-01177
`Patent No. 10,435,742
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that a true and correct copy of the foregoing PATENT
`
`OWNER’S UPDATED EXHIBIT LIST and EXHIBIT 2046 are being served on
`
`November 19, 2020, via email to Counsel for Petitioner at the email addresses
`
`below:
`
`
`
`Kerry S. Taylor
`Nathanael R. Luman
`Michael L. Fuller
`KNOBBE, MARTENS, OLSON
`& BEAR, LLP
`2040 Main Street, 14th Floor
`Irvine, CA 92614
`Email: BoxIllumina@knobbe.com
`
`
`Dated: November 19, 2020
`
`
`
`
`
`
`
`
`/John P. White/
`By:
`John P. White, Reg. No. 28,678
`Lead Attorney for Patent Owner
`Cooper & Dunham LLP
`30 Rockefeller Plaza, 20th Floor
`New York, NY 10112
`Telephone: (212) 278-0400
`Fax: (212) 391-0525
`
`
`
`
`